moving from semaglutide to tirzepatide Switching Ozempic Mounjaro | GLP-1 Alternatives what happens when you switch

In China, the foundational patent CN101133082B also expired on 20 March 2026, and with an estimated 148 million adults living with diabetes, the largest diabetic population in the world as well as a fast-growing obesity burden, the commercial opportunity is vast

AR, LewisS

Rybelsus and Ozempic are brand-name medications used to improve blood sugar in people with Type 2 diabetes

Broad Eligibility : Approved for adults with a BMI 30, or 27 with a weight-related comorbidity

GLP-1 receptor agonists lower HbA1c by 11.5% but this may be dependent of the type of GLP-1 receptor agonist prescribed, the dosage, baseline HbA1c levels and glucose-lowering co-medication [24]